IRLAB Therapeutics AB (publ) (IRLABA) Earnings Call Transcripts
About IRLAB Therapeutics AB (publ)
IRLAB Therapeutics AB (publ) (IRLABA) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on Frankfurt and is based in SE. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 17 calls on record spanning November 9, 2022 to August 27, 2025. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 17 IRLAB Therapeutics AB (publ) earnings call transcripts on record, spanning November 9, 2022 to August 27, 2025. Based on this history, IRLAB Therapeutics AB (publ) reports quarterly. The most recent call on file is dated August 27, 2025. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- IRLABA
- Exchange
- Frankfurt
- Country
- SE
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Calls on record
- 17
- First call
- November 9, 2022
- Most recent
- August 27, 2025
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Q2 FY2025 | Aug 27, 2025 | Read transcript → |
| Q1 FY2025 | May 7, 2025 | Read transcript → |
| Special Calls | Mar 28, 2025 | Read transcript → |
| Earnings Calls | Feb 12, 2025 | Read transcript → |
| Special Calls | Dec 4, 2024 | Read transcript → |
| Q3 FY2024 | Oct 30, 2024 | Read transcript → |
| Earnings Calls | Jul 10, 2024 | Read transcript → |
| Q1 FY2024 | May 8, 2024 | Read transcript → |
| Earnings Calls | Feb 7, 2024 | Read transcript → |
| Earnings Calls | Oct 25, 2023 | Read transcript → |
| Analyst/Investor Day | Oct 17, 2023 | Read transcript → |
| Company Conference Presentations | Oct 11, 2023 | Read transcript → |
| Q2 FY2023 | Aug 30, 2023 | Read transcript → |
| Special Calls | Aug 22, 2023 | Read transcript → |
| Q1 FY2023 | May 10, 2023 | Read transcript → |
| Special Calls | Jan 18, 2023 | Read transcript → |
| Earnings Calls | Nov 9, 2022 | Read transcript → |